Literature DB >> 20056711

Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein.

Toshihiko Hoashi1, Shinichi Sato, Yuji Yamaguchi, Thierry Passeron, Kunihiko Tamaki, Vincent J Hearing.   

Abstract

Melanosomes are organelles specialized for the production of melanin pigment and are specifically produced by melanocytic cells. More than 150 pigmentation-related genes have been identified, including glycoprotein nonmetastatic melanoma protein b (GPNMB). A recent proteomics analysis revealed that GPNMB is localized in melanosomes, and GPNMB is a membrane-bound glycoprotein that shows high homology with a well-known melanosomal structural protein, Pmel17/gp100. In this study, we show that GPNMB is expressed in melanocytes of normal human skin, as well as in human melanoma cells. GPNMB is heavily glycosylated and is enriched in mature (stage III and IV) melanosomes in contrast to MART-1 and Pmel17, which are abundant in early (stage I and II) melanosomes. MART-1 and Pmel17 play critical roles in the maturation of early melanosomes; thus, we speculate that GPNMB might be important in the functions of late melanosomes, possibly their transport and/or transfer to keratinocytes. We also demonstrate that a secreted form of GPNMB is released by ectodomain shedding from the largely Golgi-modified form of GPNMB and that the PKC and Ca(2+) intracellular signaling pathways regulate that shedding. We conclude that GPNMB is a melanosomal protein that is released by proteolytic ectodomain shedding and might be a useful and specific histological marker of melanocytic cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056711      PMCID: PMC2879953          DOI: 10.1096/fj.09-151019

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  74 in total

1.  Loss of S100 antigenicity in metastatic melanoma.

Authors:  Dara L Aisner; Ajay Maker; Steven A Rosenberg; David M Berman
Journal:  Hum Pathol       Date:  2005-09       Impact factor: 3.466

2.  A lumenal domain-dependent pathway for sorting to intralumenal vesicles of multivesicular endosomes involved in organelle morphogenesis.

Authors:  Alexander C Theos; Steven T Truschel; Daniele Tenza; Ilse Hurbain; Dawn C Harper; Joanne F Berson; Penelope C Thomas; Graça Raposo; Michael S Marks
Journal:  Dev Cell       Date:  2006-03       Impact factor: 12.270

3.  Sorting of Pmel17 to melanosomes through the plasma membrane by AP1 and AP2: evidence for the polarized nature of melanocytes.

Authors:  Julio C Valencia; Hidenori Watabe; An Chi; Francois Rouzaud; Kevin G Chen; Wilfred D Vieira; Kaoruko Takahashi; Yuji Yamaguchi; Werner Berens; Kunio Nagashima; Jeffrey Shabanowitz; Donald F Hunt; Ettore Appella; Vincent J Hearing
Journal:  J Cell Sci       Date:  2006-02-21       Impact factor: 5.285

4.  The repeat domain of the melanosomal matrix protein PMEL17/GP100 is required for the formation of organellar fibers.

Authors:  Toshihiko Hoashi; Jacqueline Muller; Wilfred D Vieira; Francois Rouzaud; Kanako Kikuchi; Kunihiko Tamaki; Vincent J Hearing
Journal:  J Biol Chem       Date:  2006-05-08       Impact factor: 5.157

Review 5.  The Silver locus product Pmel17/gp100/Silv/ME20: controversial in name and in function.

Authors:  Alexander C Theos; Steven T Truschel; Graça Raposo; Michael S Marks
Journal:  Pigment Cell Res       Date:  2005-10

6.  Sialylated core 1 O-glycans influence the sorting of Pmel17/gp100 and determine its capacity to form fibrils.

Authors:  Julio C Valencia; Francois Rouzaud; Sylvain Julien; Kevin G Chen; Thierry Passeron; Yuji Yamaguchi; Mones Abu-Asab; Maria Tsokos; Gertrude E Costin; Hiroshi Yamaguchi; Lisa M Miller Jenkins; Kunio Nagashima; Ettore Appella; Vincent J Hearing
Journal:  J Biol Chem       Date:  2007-02-15       Impact factor: 5.157

Review 7.  Molecular diagnostics in melanoma.

Authors:  J Andrew Carlson; Jeffery S Ross; Andrzej Slominski; Gerald Linette; Judith Mysliborski; Jerome Hill; Martin Mihm
Journal:  J Am Acad Dermatol       Date:  2005-05       Impact factor: 11.527

8.  Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.

Authors:  An Chi; Julio C Valencia; Zhang-Zhi Hu; Hidenori Watabe; Hiroshi Yamaguchi; Nancy J Mangini; Hongzhan Huang; Victor A Canfield; Keith C Cheng; Feng Yang; Riichiro Abe; Shoichi Yamagishi; Jeffrey Shabanowitz; Vincent J Hearing; Cathy Wu; Ettore Appella; Donald F Hunt
Journal:  J Proteome Res       Date:  2006-11       Impact factor: 4.466

9.  Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in mice.

Authors:  Takayuki Ogawa; Takeshi Nikawa; Harumi Furochi; Miki Kosyoji; Katsuya Hirasaka; Naoto Suzue; Koichi Sairyo; Shunji Nakano; Takashi Yamaoka; Mitsuo Itakura; Kyoichi Kishi; Natsuo Yasui
Journal:  Am J Physiol Cell Physiol       Date:  2005-09       Impact factor: 4.249

10.  CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.

Authors:  Kam Fai Tse; Michael Jeffers; Vincent A Pollack; Denise A McCabe; Melanie L Shadish; Nikolai V Khramtsov; Craig S Hackett; Suresh G Shenoy; Bing Kuang; Ferenc L Boldog; John R MacDougall; Luca Rastelli; John Herrmann; Michael Gallo; Gadi Gazit-Bornstein; Peter D Senter; Damon L Meyer; Henri S Lichenstein; William J LaRochelle
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

View more
  40 in total

1.  The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair.

Authors:  Bing Li; Ana P Castano; Thomas E Hudson; Brian T Nowlin; Shuei-Liong Lin; Joseph V Bonventre; Kenneth D Swanson; Jeremy S Duffield
Journal:  FASEB J       Date:  2010-08-13       Impact factor: 5.191

2.  Effects of pH on aggregation kinetics of the repeat domain of a functional amyloid, Pmel17.

Authors:  Candace M Pfefferkorn; Ryan P McGlinchey; Jennifer C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-24       Impact factor: 11.205

3.  Differential expression of glycoprotein non-metastatic melanoma protein B (GPNMB) involved in trichostatin A-induced apoptosis in gastric cancer.

Authors:  Wei-Min Ruan; Yun-Long Li; Gang Nie; Wen-Xue Zhou; Xiao-Ming Zou
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Rapid temporal dynamics of transcription, protein synthesis, and secretion during macrophage activation.

Authors:  Katrin Eichelbaum; Jeroen Krijgsveld
Journal:  Mol Cell Proteomics       Date:  2014-01-06       Impact factor: 5.911

5.  The PKD domain distinguishes the trafficking and amyloidogenic properties of the pigment cell protein PMEL and its homologue GPNMB.

Authors:  Alexander C Theos; Brenda Watt; Dawn C Harper; Karolina J Janczura; Sarah C Theos; Kathryn E Herman; Michael S Marks
Journal:  Pigment Cell Melanoma Res       Date:  2013-04-02       Impact factor: 4.693

Review 6.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

7.  Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy.

Authors:  Brian J Siroky; Hong Yin; Bradley P Dixon; Ryan J Reichert; Anna R Hellmann; Thiruvamoor Ramkumar; Zenta Tsuchihashi; Marlene Bunni; Joshua Dillon; P Darwin Bell; Julian R Sampson; John J Bissler
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-11

Review 8.  Melanocytes and their diseases.

Authors:  Yuji Yamaguchi; Vincent J Hearing
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-01       Impact factor: 6.915

9.  Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.

Authors:  Fabio A Zucca; Renzo Vanna; Francesca A Cupaioli; Chiara Bellei; Antonella De Palma; Dario Di Silvestre; Pierluigi Mauri; Sara Grassi; Alessandro Prinetti; Luigi Casella; David Sulzer; Luigi Zecca
Journal:  NPJ Parkinsons Dis       Date:  2018-06-05

10.  ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties.

Authors:  April A N Rose; Matthew G Annis; Zhifeng Dong; Francois Pepin; Michael Hallett; Morag Park; Peter M Siegel
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.